These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 19072342)

  • 1. ACE inhibitors and angiotensin II receptor antagonists in Crohn's disease management.
    Hume GE; Radford-Smith GL
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):645-51. PubMed ID: 19072342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias.
    Garg S; Narula J; Marelli C; Cesario D
    Am J Cardiol; 2006 Mar; 97(6):921-5. PubMed ID: 16516603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The renin-angiotensin system].
    Hilgers KF
    Urologe A; 2009 Aug; 48(8):925-33; quiz 934-5. PubMed ID: 19669119
    [No Abstract]   [Full Text] [Related]  

  • 5. A clinical approach in regression of glomerulosclerosis.
    Stoian M; Radulian G; ChiĊ£ac D; Simion E; Stoica V
    Rom J Intern Med; 2007; 45(2):215-8. PubMed ID: 18333378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
    Brewster UC; Perazella MA
    Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
    Duprez DA
    J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S
    Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.
    Zaffanello M; Franchini M; Fanos V
    Pharmacotherapy; 2008 Jan; 28(1):125-30. PubMed ID: 18154482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence and implications of aldosterone breakthrough.
    Bomback AS; Klemmer PJ
    Nat Clin Pract Nephrol; 2007 Sep; 3(9):486-92. PubMed ID: 17717561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Renin-Angiotensin system and vascular disease in diabetes.
    Deinum J; Chaturvedi N
    Semin Vasc Med; 2002 May; 2(2):149-56. PubMed ID: 16222606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there added value to adding ARB to ACE inhibitors in the management of CKD?
    Cohen DL; Townsend RR
    J Am Soc Nephrol; 2009 Aug; 20(8):1666-8. PubMed ID: 18776118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atrial fibrillation: potential therapeutic interventions in the renin-angiotensin-aldosterone system].
    Dabrowski R; Szwed H
    Kardiol Pol; 2007 Apr; 65(4):440-5. PubMed ID: 17530565
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker therapy to reduce cardiovascular events in high-risk patients: part 2.
    Bommer WJ
    Prev Cardiol; 2008; 11(4):215-22. PubMed ID: 19476574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy].
    Fronczyk A; Majkowska L
    Przegl Lek; 2007; 64(2):81-5. PubMed ID: 17892038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
    Perkins JM; Davis SN
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the central renin-angiotensin system in Parkinson's disease.
    Mertens B; Vanderheyden P; Michotte Y; Sarre S
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):49-56. PubMed ID: 19861346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of angiotensin II interruption: evidence for antiinflammatory actions.
    Dagenais NJ; Jamali F
    Pharmacotherapy; 2005 Sep; 25(9):1213-29. PubMed ID: 16164395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease.
    Re RN
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):42-7. PubMed ID: 16265259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.